TY  - BOOK
AU  - Desiraju,G.R.
AU  - Vittal,Jagadese J.
AU  - Ramanan,Arunachalam
TI  - Crystal engineering: a textbook 
SN  - 9789814366861
AV  - QD905.2 .D47 2011
PY  - 2011///
CY  - Hackensack, NJ
PB  - World Scientific, IISc Press
KW  - Crystallography
KW  - Textbooks
KW  - Crystal growth
KW  - Molecular crystals
N1  - Includes bibliographical references and index; 1.Crystal Engineering; -- 1.1.X-ray Crystallography; -- 1.2.Organic Solid State Chemistry; -- 1.3.The Crystal as a Supramolecular Entity; -- 1.4.Modern Crystal Engineering; -- 1.4.1.Horizontal and Vertical Divisions of Chemistry; -- 1.4.2.Organic Crystal Engineering; -- 1.4.3.Metal-Organic Crystal Engineering; -- 1.4.4.Properties of Crystals; -- 1.5.Summary; -- 1.6.Further Reading; -- 1.7.Problems; -- 2.Intermolecular Interactions; -- 2.1.General Properties; -- 2.2.Van Der Waals Interactions; -- 2.2.1.Close Packing; -- 2.3.Hydrogen Bonds; -- 2.3.1.Weak Hydrogen Bonds; -- 2.3.2.Hierarchies of Hydrogen Bonds; -- 2.4.Halogen Bonds; -- 2.5.Other Interactions; -- 2.6.Methods of Study of Interactions; -- 2.6.1.Crystallography; -- 2.6.2.Crystallographic Databases; -- 2.6.2.1.Graph Sets; -- 2.6.3.Spectroscopy; -- 2.6.4.Computational Methods; -- 2.6.4.1.Crystal Structure Prediction; -- 2.7.Analysis of Typical Crystal Structures; -- 2.8.Summary; -- 2.9.Further Reading; -- 2.10.Problems; -- 3.Crystal Design Strategies; -- 3.1.Synthesis in Chemistry; -- 3.2.Supramolecular Chemistry; -- 3.3.The Synthon in Crystal Engineering; -- 3.3.1.Some Representative Synthons; -- 3.3.2.The Carboxyl Dimer Synthon; -- 3.3.3.Structural Insulation in Crystal Engineering; -- 3.3.4.Discovery of New Synthons; -- 3.3.5.Two-dimensional Patterns; -- 3.3.6.Higher Dimensional Control; -- 3.3.7.Coordination Polymers as Networks; -- 3.3.8.Useful Synthons; -- 3.4.Summary; -- 3.5.Further Reading; -- 3.6.Problems; -- 4.Crystallization and Crystal Growth; -- 4.1.Crystallization of Organic Solids; -- 4.1.1.Solution Crystallization; -- 4.1.1.1.Antisolvent Crystallization; -- 4.1.2.Melt Crystallization; -- 4.1.3.Sublimation; -- 4.1.4.Hydrothermal and Solvothermal Crystallization; -- 4.1.5.Crystallization from a Solid Phase; -- 4.1.5.1.Single Crystal to Single Crystal (SCSC) Transformations; -- 4.1.5.2.Mechanochemistry; -- 4.1.6.Crystallization of Chiral Solids; -- 4.2.Nucleation; -- 4.2.1.Nucleation as Distinct from Crystal Growth; -- 4.3.Thermodynamics and Kinetics of Crystallization; -- 4.4.Crystal Growth; -- 4.4.1.The Terrace-Ledge-Kink Model of Crystal Growth; -- 4.4.2.Two-dimensional Nucleation versus Growth at Dislocations; -- 4.4.3.Ostwald Ripening; -- 4.5.Crystal Morphology and Habit; -- 4.5.1.Crystal Morphology and Crystal Symmetry; -- 4.6.Crystal Morphology Engineering; -- 4.6.1.Tailor-made Inhibitors; -- 4.7.Why is it that all Compounds don't seem to Crystallize Equally Well or Equally Quickly?; -- 4.8.Summary; -- 4.9.Further Reading; -- 4.10.Problems; -- 5.Polymorphism; -- 5.1.What is Polymorphism?; -- 5.1.1.Polymorphism and the Pharmaceutical Industry; -- 5.1.2.Some Simple Definitions; -- 5.2.Occurrence of Polymorphism; -- 5.2.1.Polymorphism and Intermolecular Interactions; -- 5.3.Thermodynamics of Polymorphism; -- 5.3.1.Free Energy Diagrams and Stability of Polymorphs; -- 5.3.2.Monotropes and Enantiotropes; -- 5.3.2.1.Burger-Ramberger Rules; -- 5.3.2.2.Distinguishing between Enantiotropes and Monotropes; -- 5.4.Thermodynamics versus Kinetics and the Fonnation of Polymorphs; -- 5.5.Methods of Polymorph Characterization; -- 5.5.1.Hot Stage Microscopy; -- 5.5.2.X-ray Diffraction; -- 5.5.3.Thermal Analysis; -- 5.6.Properties of Polymorphs; -- 5.6.1.Color; -- 5.6.2.Mechanical Properties; -- 5.6.3.Chemical Reactivity; -- 5.6.3.1.Polymorphism in Energetic Materials; -- 5.6.3.2.Polymorphism and Reactivity of Drugs; -- 5.7.Case Studies from the Pharmaceutical Industry; -- 5.7.1.Ranitidine; -- 5.7.2.Ritonavir; -- 5.7.3.Aspirin; -- 5.7.4.Omeprazole; -- 5.8.Polymorphism Today; -- 5.9.Summary; -- 5.10.Further Reading; -- 5.11.Problems; -- 6.Multi-component Crystals; -- 6.1.General Classification and Nomenclature; -- 6.2.Solid Solutions; -- 6.3.Host-Guest Compounds; -- 6.3.1.Design of Hosts; -- 6.4.Solvates and Hydrates; -- 6.5.Donor-Acceptor Complexes; -- 6.6.Co-crystals; -- 6.6.1.Hydrogen Bonded Co-crystals; -- 6.6.2.Pharmaceutical Co-crystals; -- 6.6.2.1.Design of Pharmaceutical Co-crystals; -- 6.6.2.2.Properties of Pharmaceutical Co-crystals; -- 6.6.2.3.Co-crystals and Salts; -- 6.7.Summary; -- 6.8.Further Reading; -- 6.9.Problems; -- 7.Coordination Polymers; -- 7.1.What are Coordination Polymers?; -- 7.2.Classification Schemes; -- 7.3.Crystal Design Strategies; -- 7.4.Network Topologies; -- 7.4.1.Net Symbols and Nomenclature; -- 7.4.2.Topologies of Three-dimensional Structures; -- 7.4.2.1.Diamond Topology; -- 7.4.2.2.NaCl Topology; -- 7.4.2.3.NbO and CdSO4 Topologies; -- 7.4.2.4.PtS and Related Topologies; -- 7.5.Supramolecular Isomerism; -- 7.6.Interpenetration; -- 7.7.Porous Coordination Polymers; -- 7.7.1.Pore Size; -- 7.7.2.Gas Sorption and Storage; -- 7.8.Properties and Applications; -- 7.8.1.Magnetism, Magnetic Ordering and Spin Crossover; -- 7.8.2.Luminescence and Sensing; -- 7.8.3.Nonlinear Optical Properties; -- 7.8.4.Proton Conductivity; -- 7.8.5.Ferroelectricity; -- 7.8.6.Birefringence; -- 7.8.7.Negative Thermal Expansion; -- 7.8.8.Processability; -- 7.8.9.Chemical Reactivity; -- 7.8.9.1.Structural Transformations on Heating; -- 7.8.9.2.[2+2] Cycloaddition Reactions; -- 7.8.9.3.Structural Transformations due to Loss of Solvents; -- 7.8.9.4.Reactivity of Supramolecular Isomers; -- 7.9.Building Approach: Influence of Experimental Conditions; -- 7.10.Summary; -- 7.11.Further Reading; -- 7.12.Problems
ER  -